We are live on ! Find out more
GT

Glenmede Trust Portfolio holdings

AUM $20.4B
This Fund
S&P 500
This Quarter Est. Return
-21.98%
1 Year Est. Return
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$21.9B
AUM Growth
$0
Cap. Flow
-$63.6K
Cap. Flow %
-0%
Top 10 Hldgs %
13.08%
Holding
3,173
New
Increased
3
Reduced
4
Closed

Sector Composition

Rank Sector Weight
1 Technology 18.83%
2 Financials 13.42%
3 Healthcare 13.25%
4 Industrials 9.77%
5 Consumer Discretionary 7.14%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
IRM icon
1076
Iron Mountain
IRM
$36.4B
$168K ﹤0.01%
5,316
GT icon
1077
Goodyear
GT
$2B
$167K ﹤0.01%
10,793
INVX
1078
Innovex International
INVX
$1.96B
$167K ﹤0.01%
3,570
BR icon
1079
Broadridge
BR
$17.8B
$166K ﹤0.01%
1,349
DCM
1080
DELISTED
NTT DOCOMO, Inc.
DCM
$166K ﹤0.01%
5,974
ENPH icon
1081
Enphase Energy
ENPH
$4.96B
$165K ﹤0.01%
6,321
KBWB icon
1082
Invesco KBW Bank ETF
KBWB
$6.84B
$165K ﹤0.01%
2,850
CASS icon
1083
Cass Information Systems
CASS
$714M
$164K ﹤0.01%
2,842
KRTX
1084
DELISTED
Karuna Therapeutics, Inc. Common Stock
KRTX
$164K ﹤0.01%
2,190
SCSC icon
1085
Scansource
SCSC
$1.15B
$162K ﹤0.01%
4,390
SMFG icon
1086
Sumitomo Mitsui Financial
SMFG
$164B
$162K ﹤0.01%
21,975
SXT icon
1087
Sensient Technologies
SXT
$5.26B
$161K ﹤0.01%
2,445
CEVA icon
1088
CEVA Inc
CEVA
$910M
$160K ﹤0.01%
5,970
MSA icon
1089
Mine Safety
MSA
$7.35B
$160K ﹤0.01%
1,269
NAB
1090
DELISTED
NATL AUSTRALIA BK LTD ADS5
NAB
$159K ﹤0.01%
18,474
NOVT icon
1091
Novanta
NOVT
$5.08B
$158K ﹤0.01%
1,795
SCL icon
1092
Stepan Co
SCL
$1.46B
$157K ﹤0.01%
1,535
XBI icon
1093
State Street SPDR S&P Biotech ETF
XBI
$9.95B
$157K ﹤0.01%
1,663
XLNX
1094
DELISTED
Xilinx Inc
XLNX
$157K ﹤0.01%
1,620
KB icon
1095
KB Financial Group
KB
$41.4B
$156K ﹤0.01%
3,774
PCH
1096
DELISTED
PotlatchDeltic
PCH
$156K ﹤0.01%
3,606
INXN
1097
DELISTED
Interxion Holding N.V.
INXN
$156K ﹤0.01%
1,870
APAM icon
1098
Artisan Partners
APAM
$2.79B
$155K ﹤0.01%
4,812
CGEN icon
1099
Compugen
CGEN
$222M
$154K ﹤0.01%
26,000
CRSP icon
1100
CRISPR Therapeutics
CRSP
$4.73B
$154K ﹤0.01%
2,550

Similar funds

Glenmede Trust's Q1 2020 Portfolio in Review

As of Q1 2020, Glenmede Trust held 3,173 positions worth $21.9B, unchanged from the previous quarter. Its ten largest holdings account for 13% of the portfolio.

Trading was light in Q1 2020: portfolio turnover was 0%. Glenmede Trust opened no new positions and made no exits, leaving the 3,173-position portfolio largely intact.

By sector, the portfolio is most concentrated in Technology at 19% of assets, unchanged from a quarter earlier, followed by Financials and Healthcare.

  • Glenmede Trust added most to Interpace Biosciences, Inc. Common Stock in Q1 2020, an estimated $51.9K increase.
  • Glenmede Trust's biggest Q1 2020 reduction was Brookfield Infrastructure Partners, cutting an estimated $78.8K.
  • Glenmede Trust's ten largest holdings make up 13% of its $21.9B portfolio in Q1 2020.
  • Glenmede Trust opened 0 new positions and closed 0 in Q1 2020.
  • Glenmede Trust's portfolio value was unchanged quarter-over-quarter at $21.9B.

Based on Glenmede Trust's 13F filing for Q1 2020, filed 20 May 2020.